ESOC 2024 | What’s new in ESO guidelines?

Terence Quinn, MD, MRCP, MBCHB (hons), University of Glasgow, Glasgow, UK, shares an overview of the European Stroke Organisation guidelines session that took place at ESOC 2024, emphasizing the goals of the guidelines board and their adapting approach to guideline development as trial data becomes increasingly complex. Guidelines aim to offer valuable recommendations to clinicians on topics of clinical importance. This year, updates were shared on the management of patent foramen ovale (PFO), basilar artery occlusion (BAO), intracerebral hemorrhage (ICH), and aphasia. Dr Quinn comments on several ways in which guideline development has adapted in an age of rapidly growing data volume and complexity, including the use of network meta-analyses to compare several drugs against each other and the inclusion of unpublished data to keep recommendations as up to date as possible. This interview took place at the 10th European Stroke Organisation Conference (ESOC) 2024 in Basel, Switzerland.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.